Diuretic complications
- PMID: 10653441
Diuretic complications
Abstract
Background: Diuretics are widely used and generally safe, but like any therapeutic agents, they may cause side effects.
Methods: A review of recent literature pertaining to diuretic usage was performed, with emphasis on specific reports of side effects. Reports of large-scale hypertension trials employing diuretics were also examined for descriptions of diuretic-related complications.
Results: All diuretics promote excretion of sodium. Depending upon the site and mode of action, some diuretics increase excretion of potassium, chloride, calcium, bicarbonate, or magnesium. Some can reduce renal excretion of electrolyte-free water, calcium, potassium, or protons. Consequently, electrolyte and acid-base disorders commonly accompany diuretic use. Except for the mildly natriuretic collecting duct agents, which are used mainly to limit potassium excretion, all diuretics can cause volume depletion with prerenal azotemia. Loop agents and distal convoluted tubule agents, such as the thiazides, produce hypokalemic, hypochloremic, metabolic alkalosis that responds to potassium chloride replacement. Carbonic anhydrase inhibitors produce less hypokalemia and volume depletion but commonly induce metabolic acidosis that is often symptomatic. The potassium-sparing agents also limit proton excretion, and spironolactone may produce metabolic acidosis. Hyperkalemia is a leading complication of the potassium-sparing agents, especially in patients with an underlying tendency for hyperkalemia. Thiazide diuretics, in particular, have been linked to glucose intolerance, which may be an effect of hypokalemia rather than the diuretic itself. Whether diuretic-induced hypokalemia increases cardiovascular risk is controversial. Loop agents and thiazides may lead to hyponatremia, which, in the case of thiazides, may cause permanent neurologic damage. Dose-related reversible or irreversible ototoxicity may complicate treatment with loop agents. Nephrocalcinosis, nephrolithiasis, hypomagnesemia, and hyperuricemia can potentially complicate treatment with some diuretic agents. Reported idiosyncratic reactions to diuretics include interstitial nephritis, noncardiogenic pulmonary edema, pancreatitis, and myalgias.
Conclusions: Potential side effects of a diuretic can often be anticipated from its mode of action on the kidney. These complications may be mitigated with careful monitoring, dosage adjustment, and replacement of electrolyte losses. Other side effects are idiosyncratic and cannot be prevented.
Similar articles
-
Metabolic complications associated with use of diuretics.Semin Nephrol. 2011 Nov;31(6):542-52. doi: 10.1016/j.semnephrol.2011.09.009. Semin Nephrol. 2011. PMID: 22099511 Review.
-
Drug-induced abnormalities of potassium metabolism.Pol Arch Med Wewn. 2008 Jul-Aug;118(7-8):431-4. Pol Arch Med Wewn. 2008. PMID: 18714739 Review.
-
Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs.J Am Med Dir Assoc. 2013 Jun;14(6):437-42. doi: 10.1016/j.jamda.2013.02.002. Epub 2013 Mar 17. J Am Med Dir Assoc. 2013. PMID: 23510827 Review.
-
Magnesium and potassium-sparing diuretics.Magnesium. 1986;5(5-6):282-92. Magnesium. 1986. PMID: 3543514 Review.
-
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].Nefrologia. 2008;28 Suppl 3:87-93. Nefrologia. 2008. PMID: 19018744 Spanish.
Cited by
-
Chronic hypokalaemia and nephrocalcinosis.NDT Plus. 2009 Aug;2(4):314-7. doi: 10.1093/ndtplus/sfp047. Epub 2009 Apr 22. NDT Plus. 2009. PMID: 25984026 Free PMC article. No abstract available.
-
Desirable therapeutic characteristics of an optimal antihypertensive agent.Drugs. 2006;66(9):1239-52. doi: 10.2165/00003495-200666090-00006. Drugs. 2006. PMID: 16827600 Review.
-
Choosing initial antihypertensive drug therapy for the uncomplicated hypertensive patient.J Clin Hypertens (Greenwich). 2001 Jan-Feb;3(1):37-44. doi: 10.1111/j.1524-6175.2001.990830.x. J Clin Hypertens (Greenwich). 2001. PMID: 11416681 Free PMC article.
-
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.Vasc Health Risk Manag. 2009;5(1):411-27. doi: 10.2147/vhrm.s4235. Vasc Health Risk Manag. 2009. PMID: 19475778 Free PMC article. Review.
-
Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients.Ann Intensive Care. 2016 Dec;6(1):1. doi: 10.1186/s13613-015-0096-2. Epub 2016 Jan 4. Ann Intensive Care. 2016. PMID: 26728593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical